TScan Therapeutics, Inc. TCRX
NASDAQ · United States · Health Technology
$0.3205+0.00 (+0.94%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.23 | -0.25 | +9.2% | $1.05M | -43.9% | -0.6%$0.78→$0.77 |
| Q1 2026 | 2026-05-06 | -0.22 | -0.22 | 0.0% | — | — | 0.0%$1.21→$1.21 |
| Q4 2025 | 2026-03-04 | -0.18 | -0.28 | +35.7% | — | — | +9.2%$1.03→$1.13 |
| Q3 2025 | 2025-11-12 | -0.28 | -0.35 | +20.0% | — | — | -7.4%$1.22→$1.13 |
| Q4 2024 | 2025-03-05 | -0.29 | -0.28 | -3.6% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.28 | -0.28 | 0.0% | — | — | — |
| Q1 2024 | 2024-05-13 | -0.32 | -0.24 | -33.3% | — | — | — |
| Q4 2023 | 2024-03-06 | -0.11 | -0.25 | +56.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.